Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma

Figure 5

Identification of key transcription factors (TFs) in MESO: (a) expression of differently expressed TFs in patients with MESO; (b) volcano plot showed that 5 out of 318 TFs from the Cistrome database were differently expressed in MESO versus normal samples; (c) survival analysis of TCF7L1 (left) and SDC2 (right) in pancancer; (d) effect of expression levels of TCF7L1 and SDC2 on the survival status of patients with MESO.

(a)

(b)

(c)

(d)